Organogenesis Holdings Inc (ORGO)
2.83
+0.07
(+2.54%)
USD |
NASDAQ |
Mar 28, 16:00
2.83
0.00 (0.00%)
After-Hours: 20:00
Organogenesis Holdings Price: 2.83 for March 28, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Mar 28, 2024 | 2.74 | 2.865 | 2.72 | 2.83 | 177512.0 |
Mar 27, 2024 | 2.66 | 2.78 | 2.60 | 2.76 | 406976.0 |
Mar 26, 2024 | 2.66 | 2.685 | 2.61 | 2.62 | 381010.0 |
Mar 25, 2024 | 2.63 | 2.685 | 2.585 | 2.62 | 377949.0 |
Mar 22, 2024 | 2.68 | 2.70 | 2.55 | 2.61 | 603241.0 |
Mar 21, 2024 | 2.81 | 2.85 | 2.64 | 2.66 | 411840.0 |
Mar 20, 2024 | 2.66 | 2.87 | 2.65 | 2.80 | 629707.0 |
Mar 19, 2024 | 2.79 | 2.81 | 2.715 | 2.75 | 877486.0 |
Mar 18, 2024 | 2.87 | 2.975 | 2.73 | 2.75 | 830085.0 |
Mar 15, 2024 | 2.82 | 2.89 | 2.77 | 2.85 | 1.191M |
Mar 14, 2024 | 3.00 | 3.04 | 2.82 | 2.84 | 1.365M |
Mar 13, 2024 | 2.93 | 3.045 | 2.91 | 3.00 | 766784.0 |
Mar 12, 2024 | 3.04 | 3.04 | 2.85 | 2.94 | 357443.0 |
Mar 11, 2024 | 3.11 | 3.12 | 2.935 | 2.98 | 457506.0 |
Mar 08, 2024 | 3.20 | 3.285 | 3.06 | 3.11 | 413990.0 |
Mar 07, 2024 | 2.90 | 3.165 | 2.87 | 3.13 | 1.178M |
Mar 06, 2024 | 2.84 | 2.93 | 2.70 | 2.85 | 853447.0 |
Mar 05, 2024 | 2.84 | 2.88 | 2.75 | 2.78 | 797936.0 |
Mar 04, 2024 | 2.94 | 3.01 | 2.65 | 2.88 | 1.384M |
Mar 01, 2024 | 3.09 | 3.39 | 2.52 | 2.92 | 2.457M |
Feb 29, 2024 | 3.62 | 3.65 | 3.535 | 3.57 | 568959.0 |
Feb 28, 2024 | 3.58 | 3.58 | 3.44 | 3.49 | 510961.0 |
Feb 27, 2024 | 3.53 | 3.65 | 3.51 | 3.58 | 461665.0 |
Feb 26, 2024 | 3.43 | 3.525 | 3.37 | 3.49 | 364078.0 |
Feb 23, 2024 | 3.40 | 3.475 | 3.30 | 3.46 | 414769.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.89
Minimum
Mar 24 2023
23.23
Maximum
May 03 2021
6.522
Average
4.71
Median
Jan 30 2020
Price Benchmarks
NovaBay Pharmaceuticals Inc | 0.1047 |
Palatin Technologies Inc | 1.87 |
iBio Inc | 4.06 |
Theriva Biologics Inc | 0.469 |
Ampio Pharmaceuticals Inc | 0.92 |
Price Related Metrics
PE Ratio | 79.36 |
PS Ratio | 0.866 |
Price to Book Value | 1.340 |
Price to Free Cash Flow | 57.24 |
Earnings Yield | 1.26% |
Market Cap | 373.46M |
Operating PE Ratio | 29.95 |
Normalized PE Ratio | 79.36 |